UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and Safety of Anti-EGFR Therapy Rechallenge in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Journal of gastrointestinal cancer, 2025-12, Vol.56 (1), p.9, Article 9

2025

Volltextzugriff (PDF)

Discovery of potent allosteric antibodies inhibiting EGFR

mAbs, 2024-12, Vol.16 (1), p.2406548

2024

Volltextzugriff (PDF)

A multicenter, prospective, phase II trial of second‐line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti‐EGFR antibody: HGCSG1801

International journal of cancer, 2024-12, Vol.155 (12), p.2223-2231

2024

Volltextzugriff (PDF)

'In silico' repurposing new inhibitors of EGFR and VEGFR-2 kinases via biophysical mechanisms

Journal of biomolecular structure & dynamics, 2024-12, Vol.42 (18), p.9571-9586

2024

Volltextzugriff (PDF)

In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer

Journal of biomolecular structure & dynamics, 2024-12, Vol.42 (18), p.9416-9438

2024

Volltextzugriff (PDF)

An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)

Journal of biomolecular structure & dynamics, 2024-12, Vol.42 (18), p.9795-9811

2024

Volltextzugriff (PDF)

Computer-aided anti-cancer drug discovery of EGFR protein based on virtual screening of drug bank, ADMET, docking, DFT and molecular dynamic simulation studies

Journal of biomolecular structure & dynamics, 2024-12, Vol.42 (18), p.9662-9677

2024

Volltextzugriff (PDF)

Exploring EGFR inhibitors with the aid of virtual screening, docking, and dynamics simulation studies

Journal of biomolecular structure & dynamics, 2024-12, Vol.42 (19), p.10489-10509

2024

Volltextzugriff (PDF)

Towards targeting EGFR and COX-2 inhibitors: comprehensive computational studies on the role of chlorine group in novel thienyl-pyrazoline derivative

Journal of biomolecular structure & dynamics, 2024-12, Vol.42 (19), p.9857-9872

2024

Volltextzugriff (PDF)

PPP3CB overexpression mediates EGFR TKI resistance in lung tumors via calcineurin/MEK/ERK signaling

Life science alliance, 2024-12, Vol.7 (12), p.e202402873

2024

Volltextzugriff (PDF)

Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo

Molecular biology reports, 2024-12, Vol.51 (1), p.455-455, Article 455

2024

Volltextzugriff (PDF)

Evaluation of the role of EGFR exon 19 747–750 deletion mutation and plasma amino acid profile in the development of lung cancer

Molecular biology reports, 2024-12, Vol.51 (1), p.1039, Article 1039

2024

Volltextzugriff (PDF)

MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma

Annals of medicine (Helsinki), 2024-12, Vol.56 (1), p.2313671-2313671

2024

Volltextzugriff (PDF)

Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma

Oncology reports, 2024-12, Vol.52 (6), Article 172

2024

Volltextzugriff (PDF)

Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases

Journal of enzyme inhibition and medicinal chemistry, 2024-12, Vol.39 (1), p.2311157-2311157

2024

Volltextzugriff (PDF)

Effect control of novel Hirudinaria manillensis extract on the molecular regulation of EGFR gene and its protein expression in HeLa cells

Molecular biology reports, 2024-12, Vol.51 (1), p.1061, Article 1061

2024

Volltextzugriff (PDF)

Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer

Cellular and molecular life sciences : CMLS, 2024-12, Vol.81 (1), p.272, Article 272

2024

Volltextzugriff (PDF)

The HIF-1α/PKM2 Feedback Loop in Relation to EGFR Mutational Status in Lung Adenocarcinoma

Journal of investigative surgery, 2024-12, Vol.37 (1), p.2301081-2301081

2024

Volltextzugriff (PDF)

Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors

Journal of enzyme inhibition and medicinal chemistry, 2024-12, Vol.39 (1), p.2305856-2305856

2024

Volltextzugriff (PDF)

EGFR mutations and abnormal trafficking in cancers

Molecular biology reports, 2024-12, Vol.51 (1), p.924

2024

Volltextzugriff (PDF)

Taxus chinensis var. mairei (Lemée et Lévl) Cheng et L.K. Fu overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer via suppression of ERK1/2-related cholesterol biosynthesis

Journal of ethnopharmacology, 2024-11, Vol.334, p.118586, Article 118586

2024

Volltextzugriff (PDF)

Investigating NanoLuc-EGFR engineered cell lines for real-time monitoring of EGFR protein dynamics in live cells

Biochemical and biophysical research communications, 2024-11, Vol.733, p.150711, Article 150711

2024

Volltextzugriff (PDF)

Non-small cell lung carcinoma with co-expression of TTF1 and p40: a clinicopathological analysis of six cases

Zhonghua bing li xue za zhi, 2024-11, Vol.53 (11), p.1111

2024

Volltextzugriff (PDF)

The high-grade growth pattern of invasive lung adenocarcinoma: an update

Zhonghua bing li xue za zhi, 2024-11, Vol.53 (11), p.1162

2024

Volltextzugriff (PDF)

Biochemical analysis of EGFR exon20 insertion variants insASV and insSVD and their inhibitor sensitivity

Proceedings of the National Academy of Sciences - PNAS, 2024-11, Vol.121 (45), p.e2417144121

2024

Volltextzugriff (PDF)

1 – 25 von 21.616

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20.437)
Mit Volltextzugriff
(19.478)

Publikationsform

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(19.166)
Humans
(17.711)
Life Sciences & Biomedicine
(17.563)
Erbb Receptors - Metabolism
(9.254)
Erbb Receptors - Genetics
(8.378)
Animals
(7.902)
Oncology
(7.049)
Female
(6.936)
Mutation
(5.481)
Male
(5.187)
Biochemistry & Molecular Biology
(4.300)
Epidermal Growth Factor
(4.266)
Mice
(4.214)
Lung Neoplasms - Genetics
(4.020)
Biological And Medical Sciences
(3.995)
Cell Line, Tumor
(3.986)
Epidermal Growth Factor Receptors
(3.823)
Middle Aged
(3.787)
Erbb Receptors - Antagonists & Inhibitors
(3.593)
Lung Neoplasms - Drug Therapy
(3.580)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(21.281)
EZB Electronic Journals Library
(13.754)
Ingenta
(9.248)
Journals@Ovid Full Text
(7.331)
Publisher website
(4.864)
IngentaConnect Journals
(4.325)
Elsevier ScienceDirect Journals Complete
(3.807)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.929)
Wiley Journals
(2.904)
SpringerLink
(2.127)
Wiley Online Library Full Collection 2018
(1.807)
Nature_系列刊
(1.627)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.267)
Taylor & Francis Journals
(942)
Nexis Uni
(871)
Taylor & Francis
(865)
Oxford University Press Full Collection 2022
(615)
JSTOR
(581)
Taylor & Francis Journals Complete
(571)
Oxford Journals 2020 Medicine
(436)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Biological Chemistry
(1.335)
Journal Of Biological Chemistry/the journal Of Biological Chemistry
(1.090)
Plos One
(460)
Journal Of Biological Chemistry
(421)
Proceedings Of The National Academy Of Sciences - Pnas
(331)
Annals Of Oncology
(321)
Scientific Reports
(304)
Lung Cancer
(300)
British Journal Of Cancer
(292)
Oncogene
(289)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(185)
... seit 30 Tagen
(31)

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Anti-EGFR Therapy Rechallenge in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Discovery of potent allosteric antibodies inhibiting EGFR

A multicenter, prospective, phase II trial of second‐line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti‐EGFR antibody: HGCSG1801

'In silico' repurposing new inhibitors of EGFR and VEGFR-2 kinases via biophysical mechanisms

In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer

An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)

Computer-aided anti-cancer drug discovery of EGFR protein based on virtual screening of drug bank, ADMET, docking, DFT and molecular dynamic simulation studies

Exploring EGFR inhibitors with the aid of virtual screening, docking, and dynamics simulation studies

Towards targeting EGFR and COX-2 inhibitors: comprehensive computational studies on the role of chlorine group in novel thienyl-pyrazoline derivative

PPP3CB overexpression mediates EGFR TKI resistance in lung tumors via calcineurin/MEK/ERK signaling

Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo

Evaluation of the role of EGFR exon 19 747–750 deletion mutation and plasma amino acid profile in the development of lung cancer

MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma

Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma

Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases

Effect control of novel Hirudinaria manillensis extract on the molecular regulation of EGFR gene and its protein expression in HeLa cells

Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer

The HIF-1α/PKM2 Feedback Loop in Relation to EGFR Mutational Status in Lung Adenocarcinoma

Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors

EGFR mutations and abnormal trafficking in cancers

Taxus chinensis var. mairei (Lemée et Lévl) Cheng et L.K. Fu overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer via suppression of ERK1/2-related cholesterol biosynthesis

Investigating NanoLuc-EGFR engineered cell lines for real-time monitoring of EGFR protein dynamics in live cells

Non-small cell lung carcinoma with co-expression of TTF1 and p40: a clinicopathological analysis of six cases

The high-grade growth pattern of invasive lung adenocarcinoma: an update

Biochemical analysis of EGFR exon20 insertion variants insASV and insSVD and their inhibitor sensitivity

Suchergebnisse filtern